XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows - operating activities    
Net income (loss) $ 23,704 $ 39,555
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 13,650 13,432
Deferred income taxes (2,060) (548)
Stock-based compensation expense 9,901 7,331
Accretion expense related to earnout payments 1,413 1,097
Gain on marketable securities (2,323) (2,040)
Loss on disposal of property and equipment 264 192
Impairment charges 16,224 7,246
Changes in assets and liabilities:    
Accounts receivable (51,707) (52,205)
Accounts payable (13,292) (1,657)
Accrued expenses (41,372) (197,698)
Non-cash write-offs 2,990 0
Deferred revenue 1,163 (1,622)
Income taxes recoverable and payable, net 347 6,617
Retirement and pension plan assets and liabilities 6,385 6,697
Prepaid expenses (4,057) (3,771)
Other assets and liabilities, net (987) (3,243)
Net cash used in operating activities (39,757) (180,617)
Cash flows - investing activities    
Acquisition of businesses, net of cash acquired 0 (37,953)
Capital expenditures (9,647) (9,619)
Purchases of marketable securities and investments (115,608) (75,464)
Proceeds from sales of marketable securities and investments 129,070 289,689
Net cash provided by investing activities 3,815 166,653
Cash flows - financing activities    
Repurchases of common stock 0 (904)
Cash dividends paid (9,609) (9,383)
Payment of employee tax withholdings on equity transactions (3,800) (4,141)
Acquisition earnout payments 0 (37,984)
Net cash used in financing activities (13,409) (52,412)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash 155 (2,642)
Net decrease in cash, cash equivalents and restricted cash (49,196) (69,018)
Cash, cash equivalents and restricted cash at beginning of period 412,618 355,489
Cash, cash equivalents and restricted cash at end of period $ 363,422 $ 286,471